Association Between Leptin (-2548G/A) Genes Polymorphism and Breast Cancer Susceptibility: A Meta-Analysis
- PMID: 26825898
- PMCID: PMC5291568
- DOI: 10.1097/MD.0000000000002566
Association Between Leptin (-2548G/A) Genes Polymorphism and Breast Cancer Susceptibility: A Meta-Analysis
Erratum in
-
Erratum: Association Between Leptin (-2548G/A) Genes Polymorphism and Breast Cancer Susceptibility: A Meta-Analysis: Erratum.Medicine (Baltimore). 2016 Aug 26;95(34):e577d. doi: 10.1097/01.md.0000494750.60057.7d. eCollection 2016 Aug. Medicine (Baltimore). 2016. PMID: 31265632 Free PMC article.
Abstract
Leptin is a confirmed breast cancer susceptibility gene. However, published studies reported mixed results. This meta-analysis was conducted to systematically get a more accurate estimation of the association between the Leptin (-2548G/A) gene polymorphism and breast cancer risk. To assess the effect of Leptin (-2548G/A) gene polymorphism on breast cancer susceptibility, we searched PUBMED, ISI Web of Knowledge, EMBASE, Chinese National Knowledge Infrastructure (CNKI) databases until September 2015 to identify eligible studies, without restriction. Summary odds ratios (ORs) and 95% confidence intervals (CIs) were used to evaluate the susceptibility to breast cancer. Separate analyses were conducted on features of the population such as ethnicity, source of controls, and country. A total of 9 case-control studies on Leptin (-2548G/A) gene polymorphism and breast cancer risk, including 3725 cases and 3093 case-free controls were identified. The results revealed that compared with the G allele, the A allele was associated with modestly increased risk of overall breast cancer (A vs G: OR = 1.12, 95%CI = 1.04-1.20, P = 0.002, Phet P < 0.00001). Following further stratified analyses, in the subgroup analyses by ethnicity, a significantly increased risk was observed among Caucasian (A vs G: OR = 1.11, 95%CI = 1.03-1.20, P = 0.006, Phet = 0.00001). No publication bias was found in the present study. In conclusion, our meta-analysis suggests that the Leptin (-2548G/A) gene polymorphism plays an important role in breast cancer susceptibility, especially in Caucasian.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures
References
-
- Siegel R, Naishadham D, Jemal A, et al. Cancer statistics, 2013. CA Cancer J Clin 2013; 63:11–30. - PubMed
-
- Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343:78–85. - PubMed
-
- Hulka BS, Moorman PG. Breast cancer: hormones and other risk factors. Maturitas 2001; 38:103–113. - PubMed
-
- Zhao E, Cui D, Yuan L, et al. MDM2 SNP 309 polymorphism and breast cancer risk: a meta-analysis. Mol Biol Rep 2012; 39:3471–3477. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
